PMDA drug package insert
オイグルコン錠1.25mg
PMDA Prescription drug · 太陽ファルマ株式会社 · package insert Feb 25, 2025
Key facts
| Brand names | オイグルコン錠1.25mg, オイグルコン錠2.5mg |
|---|---|
| Nonproprietary names | グリベンクラミド |
| Companies | 製造販売元／太陽ファルマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 経口血糖降下剤 |
| Therapeutic category codes | 873961 |
| YJ codes | 3961003F1028, 3961003F2024 |
| Approval numbers | 15300AMZ00886, 14600AMZ00400 |
| Package insert edition | 第2版 |
| Package insert date | Feb 25, 2025 |
| PMDA document key | 431010_3961003F1028_4 |
| PMDA company code | 431010 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: